Related Experiment Videos
Alternative sources of biologically active substances
1Institute of Microbiology, Academy of Sciences of the Czech Republic, 142 20 Prague, Czechia. behal@biomed.cas.cz
Folia Microbiologica
|February 24, 2004
Summary
Actinomycetes are key producers of medicinal antibiotics and bioactive compounds. Researchers are exploring diverse microorganisms for novel metabolites with therapeutic potential.
Area of Science:
- Microbiology
- Natural Product Chemistry
- Drug Discovery
Background:
- Actinomycetes, nonfilamentous bacteria and fungi, are primary sources of clinically used antibiotics and bioactive substances.
- The continuous need for new therapeutic agents drives the search for novel metabolites from diverse microbial sources.
Purpose of the Study:
- To highlight the significance of actinomycetes in producing medically important compounds.
- To underscore the ongoing investigation of various microbial groups for new biologically active metabolites.
Main Methods:
- Review of literature on microbial production of bioactive compounds.
- Identification and characterization of metabolites from diverse microorganisms.
Main Results:
- Actinomycetes are established producers of a majority of antibiotics and other bioactive substances.
- Exploration of myxobacteria, pseudomonads, nocardias, basidiomycetes, marine microorganisms, enterobacteria, halobacteria, and hyperthermophiles is underway for novel metabolites.
Conclusions:
- Actinomycetes remain a cornerstone for antibiotic and bioactive compound discovery.
- Expanding the scope of microbial investigation is crucial for identifying new therapeutic agents.